{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pfam:PF00531",
      "entity_text" : "death",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:10182969",
      "entity_text" : "Apixaban",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In this study, Apixaban decreased the risk of stroke or systemic embolism by 21%, major bleeding by 31%, and death by 11% compared to Warfarin.",
  "reading_complete" : "2020-08-03T10:14:34Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T10:13:20Z",
  "trigger" : "decreased",
  "evidence" : [ "Apixaban decreased the risk of stroke or systemic embolism by 21%, major bleeding by 31%, and death" ],
  "pmc_id" : "6332814",
  "score" : 0
}